Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Research from University of Zurich, World Health Organization provides new data on immunization
August 27th, 2008
"Question under study: To assess clinical reactions, immune responses and adverse events to undiluted, three- and sixfold diluted Lister strain vaccine stockpiled in Switzerland. A prospective, triple-blinded, randomised, parallel group clinical trial was performed," scientists writing in the journal Swiss Medical Weekly report. "From 2001 to 2007 104 persons with an indication for vaccinia vaccination were recruited. They had a median age of 3 3 years (range 18-65), 56 (53.8%) were re-vaccinees and 48 (46.2%) primary vaccinees. There was no statistically significant variation in the proportion of re-vaccinees between diluted and undiluted vaccine groups (75% vs...
Source: Vaccine Weekly (2008-08-27)
|
